Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger

Core Viewpoint - STAAR Surgical Company has received a favorable recommendation from Institutional Shareholder Services regarding its merger with Alcon, urging stockholders to vote in favor of the amended merger agreement [1] Company Summary - STAAR Surgical Company is recognized as the global leader in phakic IOLs, specifically with its EVO family of Implantable Collamer® Lenses designed for vision correction [1] Industry Context - The recommendation from ISS reflects a positive outlook on the merger, which may influence shareholder sentiment and the overall market perception of STAAR's strategic direction [1]